Clinical trial
The Pharmacokinetics of SAquinavir (Invirase New Tablet Formulation) 1,000mg + Ritonavir (Norvir) 100mg q12h in HIV-infected Pregnant Women (SARA)
NCT00145561 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Pharmacokinetics of SAquinavir (Invirase New Tablet Formulation) 1,000mg + Ritonavir (Norvir) 100mg q12h in HIV-infected Pregnant Women (SARA)
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2005
- Completion date
- February 29, 2008
- Enrollment
- 40 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.